Mark J Rosenblum's Net Worth

-$50.4 Thousand

Estimate Recalculated Sep 9, 2024 12:31AM EST

Who is Mark J Rosenblum

Mark J Rosenblum does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HEMOBIOTECH INC, Salarius Pharmaceuticals, Inc., Advaxis, Inc., and ACTIVECARE, INC..

SEC CIK

Mark J Rosenblum's CIK is 0001329154

Past Insider Trading and Trends

2020 was Mark J Rosenblum's most active year for acquiring shares with 7 total transactions. Mark J Rosenblum's most active month to acquire stocks was the month of October. 2014 was Mark J Rosenblum's most active year for disposing of shares, totalling 3 transactions. Mark J Rosenblum's most active month to dispose stocks was the month of December. 2005 saw Mark J Rosenblum paying a total of $66,750.00 for 77,000 shares, this is the most they've acquired in one year. In 2014 Mark J Rosenblum cashed out on 9,937 shares for a total of $40,068.19, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HEMOBIOTECH INC

Chief Financial Officer
Updated Mar 09, 2009
Form 4
28.48%
65.00K
Mar 09, 2009
293.23K
Grant
Mar 04
Form 4
57.14%
100.00K
Apr 25, 2008
275.00K
Grant
Apr 23
Form 4
75.00%
75.00K
Apr 03, 2007
175.00K
Grant
Mar 30
Form 4
33.33%
25.00K
Apr 25, 2006
100.00K
Grant
Mar 31
Form 4
77.00K
$1.18
$66.75K
Nov 23, 2005
77.00K
Purchase
Apr 01 - Nov 21
Form 3
Jun 08, 2005
Showing 6 results

Salarius Pharmaceuticals, Inc.

Exec VP Finance, CFO
Updated Feb 22, 2024
Form 4
22.50K
Feb 22, 2024
22.50K
Grant
Feb 20
Form 4
41.71%
6.43K
Feb 15, 2023
21.85K
Grant
Feb 13
Form 4
107.83%
8.00K
Jan 05, 2023
15.42K
Grant
Jan 03
Form 4/A
25.09%
1.49K
$1.73
$2.58K
Dec 12, 2022
7.42K
Grant
Nov 03
Form 4/A
123.32%
7.31K
$1.73
$12.68K
Nov 08, 2022
13.25K
Grant
Nov 03
Form 4
4.93%
7.31K
$1.73
$12.68K
Nov 07, 2022
155.63K
Grant
Nov 03
Form 4
23.27%
28.00K
$0.18
$5.04K
May 31, 2022
148.32K
Purchase
May 31
Form 4
9.06%
10.00K
$0.19
$1.86K
May 05, 2022
120.32K
Grant
May 03
Form 4
223.77%
76.25K
$0.39
$29.81K
Mar 09, 2022
110.32K
Purchase
Mar 03
Form 4
200.00K
Jan 21, 2022
200.00K
Grant
Jan 20
Form 4
29.62%
7.79K
$0.72
$5.59K
Nov 05, 2021
34.07K
Grant
Nov 03
Form 4
57.18%
9.56K
$0.57
$5.42K
May 05, 2021
26.29K
Grant
May 03
Form 4
80.00K
Dec 04, 2020
80.00K
Grant
Dec 02
Form 4
39.36%
4.72K
$0.56
$2.65K
Nov 05, 2020
16.72K
Grant
Nov 03
Form 4
71.43%
5.00K
$1.00
$5.00K
Aug 18, 2020
12.00K
Purchase
Aug 17
Form 4
49.95K
Jul 16, 2020
49.96K
Grant
Jul 14
Form 4
30.00K
Mar 25, 2020
30.00K
Grant
Mar 23
Form 4
40.00%
2.00K
$0.95
$1.90K
Feb 20, 2020
7.00K
Purchase
Feb 19
Form 4
5.00K
$0.86
$4.30K
Feb 13, 2020
5.00K
Purchase
Feb 13
Form 3/A
Sep 13, 2019
Form 3
Sep 12, 2019
Showing 21 results

Advaxis, Inc.

Chief Financial Officer
Updated Feb 04, 2014
Form 4
0.43%
482.00
$4.49
-$215.52
Feb 04, 2014
113.77K
Grant
Jan 31
Form 4
424.11%
91.68K
$4.03
-$33.55K
Jan 09, 2014
113.29K
Grant
Jan 07
Form 4
7.03%
1.42K
$4.03
-$6.31K
Jan 09, 2014
21.62K
Grant
Jan 07
Form 4
219.62%
18.00K
$4.00
$48.01K
Oct 28, 2013
28.90K
Purchase
Oct 24
Form 4
2.40M
Jul 10, 2013
2.40M
Grant
Mar 14
Form 4
98.04K
May 16, 2012
691.92K
Acq/Dis
May 14
Form 4
2.10M
Nov 10, 2011
2.10M
Grant
Nov 08
Form 4
588.24K
Nov 02, 2011
196.08K
Grant
Oct 31
Form 4
1.20M
Oct 18, 2010
1.20M
Grant
Oct 14
Form 3
Jan 12, 2010
Showing 10 results

ACTIVECARE, INC.

Chief Executive Officer
Updated Dec 19, 2017
Form 3
Dec 19, 2017
Showing 1 results